Kāhu Overview
- Founded
- 2021
- Status
- Private
- Latest Deal Type
- Early Stage VC
- Latest Deal Amount
- $3M
- Investors
- 2
Kāhu General Information
Description
Developer of cancer detection technology intended for early detection of skin cancer. The company utilizes artificial intelligence along with a skin image database to analyze images of a patient's skin and detect signs of melanoma, enabling doctors to better support their clinical diagnosis and management of a broad range of skin cancers.
Contact Information
Website
www.kahu.ai
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Diagnostic Equipment
Primary Office
- Auckland
- New Zealand
Kāhu Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Early Stage VC | 07-Jul-2021 | $3M | 000 | Completed | Generating Revenue |
Kāhu Executive Team (2)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Stuart Dalrymple | Chief Executive Officer & Managing Director | ||
| Yaniv Gal | Chief Technology Officer |
Kāhu Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| Pioneer Capital | Growth/Expansion | Minority | 000 0000 | 000000 0 | |
| Precision Driven Health | Venture Capital | Minority | 000 0000 | 000000 0 |